United Kingdom · Question · Written question
UIN 1459
Graft versus Host Disease: Medical Treatments
Original
Introduced
13 November 2023
Last action
22 November 2023 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
22 November 2023
Summary
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help ensure that (a) NICE, (b) NHS England and (c) he pharmaceutical industry work together to increase patient access to new therapies for Graft-versus-host
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
13 November 2023
Written question
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help ensure that (a) NICE, (b) NHS England and (c) he pharmaceutical industry work together to increase patient access to new therapies for Graft-versus-host
Source: Commons
22 November 2023
Answer
The National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing authoritative, evidence-based guidance for the National Health Service on whether new medicines represent a clinically- and cost-effective use ...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2023-11-13/1459
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1669433
- uk · wq-1669433 · source updated 22 November 2023